China’s State Food and Drug Administration (SFDA) has wrapped up a public consultation on the reclassification of 745 in vitro diagnostic (IVD) reagents as part of an effort to develop a more sophisticated device classification system. But some industry groups had hoped the draft list would go further to ease requirements for low-risk products.
International Medical Device Regulatory Monitor